Feb 10, 2022 / 10:00PM GMT
Operator
Greetings. Welcome to the VistaGen Therapeutics third quarter of fiscal year 2022 results conference call. (Operator Instructions) And please note that this conference is being recorded. I will now turn the conference over to your host, Mark Flather, Vice President of Investor Relations. Thank you. You may begin.
Mark Flather - VistaGen Therapeutics, Inc. - VP, Investor Relations
Thank you, John. Hello and welcome to VistaGen's conference call covering our fiscal year 2022 third-quarter financial results, recent accomplishments and anticipated milestones. I am Mark Flather, Vice President of Investor Relations at VistaGen. Thank you for joining us today and welcome to our stockholders, analysts, and anyone taking an interest in VistaGen.
Joining me today are Shawn Singh, our Chief Executive Officer; Jerry Dotson, our Chief Financial Officer; and Dr. Mark Smith, our Chief Medical Officer. Format for this call will consist of prepared remarks from management, followed by a brief opportunity for questions. This call is being webcast and will be available
Q3 2022 VistaGen Therapeutics Inc Earnings Call Transcript
Feb 11, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers